Attitudes and Intentions of Health Personnel towards Covid-19 Vaccination in Kaziba Health Zone

Download Article

DOI: 10.21522/TIJAR.2014.09.04.Art013

Authors : Bontango Kweme Frederic, Yassa, Bafuka, Selemani, Kaswa, Zawadi


Introduction: SARS-CoV-2 is a virus of the coronavidae family and of the beta coronavirus group, such as those responsible for SARS and MERS. This Covid-19 is more contagious than SARS and MERS but with a lower death rate. Covid-19 vaccine is a pharmaceutical tool to control the transmission of Covid-19 among the health personnel and the general population. The acceptance of Covid-19 vaccination remains reluctant among the health personnel. The purposes of this study are to determine the intentions and attitudes of health personnel vis-à-vis to Covid-19 vaccination and, to determine the reasons for accepting and refusing Covid-19 vaccination among health personnel in Kaziba Health Zone from 15 to 28 July 2021. Material and methods: our study was descriptive retrospective cross-sectional study. A random sampling method was carried out to collect the data through survey questionnaire with 102 health personnel. The data was analyzed with SPSS and Chi-square test was carried out. Results: the intentions and attitudes of the health personnel vis-à-vis to Covid-19 vaccination was (31.4%), and the participants who declared the mandatory Covid-19 vaccination was 31.4%. The health personnel who accepted the covid-19 vaccine were 21.6%, however, those who refused was 45.1%. Conclusion: health personnel do not have acceptable intentions and attitudes towards Covid-19 vaccination. Only nurses and midwives, physicians and healthcare assistance staff were agreeable to Covid-19 vaccination to control the pandemic. Lack of information was the main refusal reason for Covid-19 vaccination. The health personnel were not willingly too mandatory Covid-19 vaccination.

Keywords: Attitudes, Covid-19, Health personnel, Intentions, Kaziba, SARS-CoV-2, Vaccination.


[1] Banerjee, A., Kulcsar, K., Misra, V., Frieman, M., & Mossman, K., 2019, Bats and Coronaviruses. Viruses, 11(1), 41.

[2] WHO. (2020, February 12). Covid-19 Public Health Emergency of International Concern (PHEIC) Global Research and Innovation Forum. Retrieved August 9, 2021, from

[3] CDC. (2021, August 17). Benefits of Getting a Covid-19 Vaccine. Centers for Disease Control and Prevention. Retrieved September 9, 2021, from

[4] Yang, J., Marziano, V., Deng, X., Guzzetta, G., Zhang, J., Trentini, F., Cai, J., Poletti, P., Zheng, W., Wang, W., Wu, Q., Zhao, Z., Dong, K., Zhong, G., Viboud, C., Merler, S., Ajelli, M., & Yu, H., 2021, To what extent do we need to rely on non-pharmaceutical interventions while Covid-19 vaccines roll out in 2021? MedRxiv, 12.

[5] Wang, B., & Ping, Y., 2022, A comparative analysis of Covid-19 vaccination certificates in 12 countries/regions around the world: Rationalizing health policies for international travel and domestic social activities during the pandemic. Health Policy, 126(8), 755–762.

[6] WHO. (2021, April 19). Statement on the seventh meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (Covid-19) pandemic. Retrieved August 27, 2021, from

[7] WHO. (2020, November 13). Feuille de route du SAGE de l’OMS pour l’établissement des priorités concernant l’utilisation des vaccins anti-Covid-19 dans un contexte d’approvisionnement limité. Retrieved August 31, 2021, from

[8] Africa Centres for Disease Control and Prevention. (2021, August 24). Concerns about Capacity and Capability of Africa’s Public Health Institutions. Retrieved 21–08-30, from

[9] WHO. (2020a, June 29). Chronologie de l’action de l’OMS face à la Covid-19. Retrieved August 15, 2021, from

[10] Voysey, M., Costa Clemens, S. A., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., Bibi, S., Briner, C., Cicconi, P., Clutterbuck, E. A., Collins, A. M., Cutland, C. L., Darton, T. C., Dheda, K., Dold, C, Zuidewind, P., 2021, Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomized trials. The Lancet, 397(10277), 881–891.

[11] Chan, J. F. W., Lau, S. K. P., To, K. K. W., Cheng, V. C. C., Woo, P. C. Y., & Yuen, K. Y., 2015, Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease. Clinical Microbiology Reviews, 28(2), 465–522.

[12] Shim, E., Tariq, A., Choi, W., Lee, Y., & Chowell, G., 2020, Transmission potential and severity of Covid-19 in South Korea. International Journal of Infectious Diseases, 93, 339–344.

[13] Boseley, S., & Oltermann, P., 2020, Hopes rise for end of pandemic as Pfizer says vaccine has 90% efficacy. The Guardian. Retrieved July 31, 2021, from

[14] Ledda, C., Costantino, C., Cuccia, M., Maltezou, H. C., & Rapisarda, V., 2021, Attitudes of Healthcare Personnel towards Vaccinations before and during the Covid-19 Pandemic. International Journal of Environmental Research and Public Health, 18(5), 2703.

[15] Detoc, M., Bruel, S., Frappe, P., Tardy, B., Botelho-Nevers, E., & Gagneux-Brunon, A., 2020, Intention to participate in a Covid-19 vaccine clinical trial and to get vaccinated against Covid-19 in France during the pandemic. Vaccine, 38(45), 7002–7006.

[16] Loomba, S., de Figueiredo, A., Piatek, S. J., de Graaf, K., & Larson, H. J., 2021, Measuring the impact of Covid-19 vaccine misinformation on vaccination intent in the UK and USA. Nature Human Behaviour, 5(3), 337–348.

[17] Nachega, J. B., Sam-Agudu, N. A., Masekela, R., van der Zalm, M. M., Nsanzimana, S., Condo, J., Ntoumi, F., Rabie, H., Kruger, M., Wiysonge, C. S., Ditekemena, J. D., Chirimwami, R. B., Ntakwinja, M., Mukwege, D. M., Noormahomed, E., Paleker, M., Mahomed, H., Tamfum, J. J. M., Zumla, A., & Suleman, F., 2021, Addressing challenges to rolling out Covid-19 vaccines in African countries. The Lancet Global Health, 9(6), e746–e748.

[18] Riccò, M., Ferraro, P., Peruzzi, S., Balzarini, F., & Ranzieri, S., 2021, Mandate or Not Mandate: Knowledge, Attitudes, and Practices of Italian Occupational Physicians towards SARS-CoV-2 Immunization at the Beginning of Vaccination Campaign. Vaccines, 9(8), 1–16.

[19] Halbrook, M., Martin-Blais, R., Gray, A., Tobin, N. H., Ferbas, K. G., Aldrovandi, G. M., & Rimoin, A. W., 2021, Cross-sectional Assessment of Covid-19 Vaccine Acceptance among Health Care Workers in Los Angeles. Annals of Internal Medicine.

[20] Verger, P., Scronias, D., Dauby, N., Adedzi, K. A., Gobert, C., Bergeat, M., Gagneur, A., & Dubé, E., 2021, Attitudes of healthcare workers towards Covid-19 vaccination: a survey in France and French-speaking parts of Belgium and Canada, 2020. Eurosurveillance, 26(3).

[21] Kose, S., Mandiracioglu, A., Sahin, S., Kaynar, T., Karbus, O., & Ozbel, Y., 2020, Vaccine hesitancy
of the Covid‐19 by health care personnel. International Journal of Clinical Practice, 75(5), 1–4.

[22] Helmy, Y. A., Fawzy, M., Elaswad, A., Sobieh, A., Kenney, S. P., & Shehata, A. A., 2020, The Covid-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. Journal of Clinical Medicine, 9(125), 22.

[23] Castaneda-Vasquez, D. E., & Ruiz-Padilla, J. P., 2021, Vaccine Hesitancy against SARS-CoV-2 in Health Personnel of Northeastern Mexico and Its Determinants. JOEM, 63(8), 4.

[24] Khamis, F., Badahdah, A., al Mahyijari, N., al Lawati, F., al Noamani, J., al Salmi, I., & al Bahrani, M., 2021, Attitudes towards Covid-19 Vaccine: A Survey of Health Care Workers in Oman. Journal of Epidemiology and Global Health, 12(1), 1–6.

[25] Adane, M., Ademas, A., & Kloos, H., 2022, Knowledge, attitudes, and perceptions of Covid-19 vaccine and refusal to receive Covid-19 vaccine among healthcare workers in northeastern Ethiopia. BMC Public Health, 22(1), 1–12.